Status:
COMPLETED
Association Between Plasma Melatonin and No-reflow
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
ST-segment Elevation Myocardial Infarction
Eligibility:
All Genders
18-80 years
Brief Summary
ST-segment elevation myocardial infarction (STEMI) is an acute manifestation of coronary heart disease, remaining a frequent cause of death. A better understanding of risk factors and pathogenic mecha...
Eligibility Criteria
Inclusion
- a diagnosis of STEMI and needed PCI
Exclusion
- patients with cancer patients who used melatonin
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
1700 Patients enrolled
Trial Details
Trial ID
NCT03306303
Start Date
January 1 2014
End Date
October 1 2017
Last Update
October 11 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.